EDEN PARK ILLUMINATION, INC.
Far-UVC (222 nm) excimer lamps for antimicrobial disinfection in occupied spaces
- Sector
- Medtech
- Headquarters
- Champaign, IL
- Latest Form D
- $600K, Jan 2014
- Total capital
- $12.4M
- Federal grants
- $3.8M
- 6 awards · 2015–2025
- Rank in peer group#239 of 538
- Private capital raised
- $8.6M
- 4 Form D · last Jan 2014
- 154 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Federal grantAgriculture · Food Safety Is Critical, With Foodborne Outbreaks Causing Serious Health Risks And An Estimated $15.6 Billion Annual Economic Impact. Current Decontamination Methods Face Challenges--chemical Treatments Pose Health And Environmental Concerns, While Physical Techniques Require High Energy And Cost. Fda-approved Uv-c Technology Is Emerging As A Promising Solution.far Uv-c (222 Nm) Light Offers Enhanced Disinfection While Being Safer For Human Exposure, Unlike Traditional Uv-c.?when Combined With 4$175K
- Federal grantHealth and Human S · Phase II · Monochromatic 222 nm UV light: Development of a safe, cost-effective technology for the efficient reduction of bacterial and viral infection and transmission$496K
- Federal grantHealth and Human S · Phase II · Monochromatic 222 nm UV light: Development of a safe, cost-effective technology for the efficient reduction of bacterial and viral infection and transmission$996K
- Federal grantEnergy · Phase II · Development of Low Temperature Microplasma Lamps for Biomedical Applications$1M
- Federal grantHealth and Human S · Phase I · Monochromatic 222 nm UV light: Development of a safe, cost-effective technology for the efficient reduction of bacterial and viral infection and transmission$150K
- Federal grantEnergy · Phase II · Large scale, Low Temperature, Microplasma UV Lighting Tiles for Water Purification and Sterilization$1M
- Private capital raisedForm D · SEC · 4th filing$600K
- Private capital raisedForm D · SEC · 3rd filing$1.1M
- Private capital raisedForm D · SEC · 2nd filing$3.1M
- Private capital raisedForm D · SEC · 1st filing$3.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#239 · top 44%
- Linked publications#17 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Cyrus HerringResearcherExecutive OfficerLinked by $1M in grants as PI
- Sung-Jin ParkResearcherExecutive OfficerLinked by $2.6M in grants as PI
- Anthony Gary GroverDirectorNamed in SEC Form D filings
- Cy HerringExecutive Officer, DirectorNamed in SEC Form D filings
- Dee S. OsbornePromoterNamed in SEC Form D filings
- James Garry EdenDirectorNamed in SEC Form D filings
Show all 30 people
- J. Gary EdenExecutive Officer, DirectorNamed in SEC Form D filings
- Jeffrey BulsonExecutive OfficerNamed in SEC Form D filings
- John Gary ReganExecutive Officer, DirectorNamed in SEC Form D filings
- N/A G. Eden Park Brookfield Investments, LLCPromoterNamed in SEC Form D filings
- N/A Gary EPI Holdings, LLCPromoterNamed in SEC Form D filings
- N/A G. Illini - ITECPromoterNamed in SEC Form D filings
- N/A Gary Illinois Emerging Technologies Fund, L.P.PromoterNamed in SEC Form D filings
- N/A G. Illinois Ventures, LLCPromoterNamed in SEC Form D filings
- N/A G. Peter M. Gaines 2002 Trust Under Trust Agreement dated as of December 29, 2002PromoterNamed in SEC Form D filings
- N/A G. Richard A. May Decl of Trust DTD 07/08/1997PromoterNamed in SEC Form D filings
- N/A Gary Richard A. May Decl of Trust DTD 7/8/97PromoterNamed in SEC Form D filings
- N/A Gary Ronald N. Weiser TrustPromoterNamed in SEC Form D filings
- N/A Gary RPM Ventures II, LPPromoterNamed in SEC Form D filings
- N/A Gary The Dick and Diane May Foundation, Inc.PromoterNamed in SEC Form D filings
- N/A G. Yellowstone Energy Ventures II (Affiliate), L.P.PromoterNamed in SEC Form D filings
- N/A G. Yellowstone Energy Ventures II, L.P.PromoterNamed in SEC Form D filings
- Philip G. WarnerExecutive Officer, DirectorNamed in SEC Form D filings
- Randy CothersExecutive OfficerNamed in SEC Form D filings
- Richard G. MayDirector, PromoterNamed in SEC Form D filings
- Ron H. van OsExecutive OfficerNamed in SEC Form D filings
- Timothy Gary KudronDirectorNamed in SEC Form D filings
- Tom ParkinsonDirectorNamed in SEC Form D filings
- William H. BrewerDirectorNamed in SEC Form D filings
- William H. ThalheimerExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingDevices And Systems For Using, Monitoring And Controlling Far Ultraviolet-c Radiation And Methods Of Using Such Devices And SystemsUSPTOApplication 19305150
- PendingDevices And Systems For Using, Monitoring And Controlling Far Ultraviolet-c Radiation And Methods Of Using Such Devices And SystemsUSPTOApplication 63685128
- PendingUltraviolet And Vacuum Ultraviolet Lamps Driven By Molecular-atomic, Atomic-atomic, Or Atomic-molecular Excitation TransferUSPTOApplication PCTUS2023030787
Show all 5 patent records
- Devices And Systems For Using, Monitoring And Controlling Far Ultraviolet-c Radiation And Methods Of Using Such Devices And SystemsFeb 26, 2026 · Application 19305150Pending
- Devices And Systems For Using, Monitoring And Controlling Far Ultraviolet-c Radiation And Methods Of Using Such Devices And SystemsApplication 63685128Pending
- Ultraviolet And Vacuum Ultraviolet Lamps Driven By Molecular-atomic, Atomic-atomic, Or Atomic-molecular Excitation TransferApplication PCTUS2023030787Pending
- Planar Plasma Lamp And Method Of ManufactureApplication PCTUS2012038682Pending
- Method Of Sealing And Spacing Planar Emissive DevicesApplication PCTUS2012021111Pending
Recent research by its founders
- Mitochondrial dysfunction and fibrosis in atrial fibrillation: Molecular signaling in fast-pacing organoid models20251 cites
- P31-08 Evaluation of Repeated-Dose Toxicity and Safety of a Plant-Derived SARS-CoV-2 S1 Vaccine in New Zealand White Rabbits20250 cites
- Room-temperature deposition of large-area dielectric thin films via vacuum ultraviolet (VUV) photo-processes synthesis20250 cites
Related companies, and why
- Frontier Diagnostics, LLCSimilar federal contract value in Medtech · null in contracts
- RYTEK MEDICAL INCSimilar federal contract value in Medtech · null in contracts
- Augmental Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- Avalign Technologies Holdings, Inc.Similar federal contract value in Medtech · null in contracts
- Protect3d, Inc.Similar federal contract value in Medtech · null in contracts
- NOVOPEDICS INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .